Skip to main content

Table 2 Survival analysis of HCC patients treated with TACE

From: Arterial chemoembolization for patients with hepatocellular carcinoma and elevated lactate dehydrogenase is associated with low survival: a cohort study

Group

Median survival (month)

1-year survival rate (%)

3-year survival rate (%)

5-year survival rate (%)

χ2

P

ΔLDH ≤ − 80 U/L

21.5

66.5

40.2

28.6

35.587

< 0.001

ΔLDH witnin ± 80 U/L

32.4

74.2

47.4

37.8

  

ΔLDH ≥ 80 U/L

9.3

44.6

22.2

16.0

  
Back to article page

Infectious Agents and Cancer

ISSN: 1750-9378

Contact us